Staphylococcal infections in the intensive care unit

Seminars in Respiratory Infections

Volumn 15, Issue 4, 2000, Pages 308-313

  McGahee, Wendy ^a   Lowy, Franklin D ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CIPROFLOXACIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; NAFCILLIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; STAPHYLOCOCCUS VACCINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; COAGULASE NEGATIVE STAPHYLOCOCCUS; HAND WASHING; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; WOUND INFECTION;

EID: 0034494039     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2000.20941     Document Type: Article

References (51)

1. Anlimicrobial resistance in hospitals and outpatients in the United States: The increasing importance of the intensive care unit
2. Antimicrobial resistance in intensive care units
3. Nosocomial bloodstream infection in critically ill patients
4. Nosocomial bloodstream infections in United States hospitals: A three-year analysis
5. Carriage of Staphylococcus aureus in random samples of a normal population
6. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection
7. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks
8. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillinresistant and methicillin-susceptible strains
9. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection
10. The relation between the nasal-staphylo-coccal-carrier state and the incidence of postoperative complications
11. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery
12. Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive care unit: Efficacy of mupirocin ointment
13. New approaches to reduce Staphylococcus aureus nosocomial infection rates: Treating S. aureus nasal carriage
14. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus
15. A cloud adult: The Staphylococcus aureus-virus interaction revisited
16. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients
17. Staphylococcus aureus infections
18. Staphylococcus epidermidis: A significant nosocomial pathogen
19. Update on clinical significance of coagulase-negative staphylococci
20. National Nosocomial Infections Surveillance System Report, data summary from January 1990-May 1999, issued June 1999
21. Major trends in the microbial etiology of nosocomial infection
22. The clinical significance of positive blood cultures in the 1900s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults
23. The positive predictive value of isolating coagulase-negative staphylococci from blood cultures
24. Δ APACHE II for predicting course and outcome of nosocomial Staphylococcus aureus bacteremia and its relation to host defense
25. Clinical and epidemiological findings in mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia
26. Pneumonia due to Staphylococcus aureus during mechanical ventilation
27. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients
28. Hospital-acquired pneumonia: Methicillin resistance and intensive care unit admission
29. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms
30. Hospital-acquired infectious endocarditis not associated with cardiac surgery: An emerging problem
31. Prosthetic valve endocarditis resulting from nosocomial bactaremia: A prospective, multicenter study
32. Ventilator-associated sinusitis: A review
33. The expression in Staphylococcus aureus of cloned DNA encoding methicillin resistance
34. Cloning and expression of methicillin resistance from Staphylococcus epidermidis in Staphylococcus carnosus
35. Low-affinity penicillin-binding proteins associated with β-lactam resistance Staphylococcus aureus
36. Emergence of vancomycin resistance in coagulase-negative staphylococci
37. Emergence of vancomycin resistance in Staphylococcus aureus
38. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
39. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus
40. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus
41. Quinupristin/dalfopristine: A novel selective-spectrum antibiotic for the treatment of multi-resistant and other gram-positive pathogens
42. Treatment of hospitalized patients with complicated gram positive skin and skin structure infections: Two randomized, multicentre studies of quinupristin/dalfopristin verusus cafazolin, oxacillin or vancomycin
43. Salata RA: Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections
44. Skin hygiene and infection prevention: More of the same or different approaches
45. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin
46. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: Efficacy of antibiotic prophylaxis
47. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high risk hospital areas with a high level of endemic MRSA
48. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment
49. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysacchride in a model of endocarditis in rats
50. Vaccination with a recombinant fragment of collagen-adhesin provides protection against Staphylococcus aureus-mediated septic death